Results 101 to 110 of about 828,696 (364)

Hemophilus Influenzae Vaccine and Guillain-Barre

open access: yesPediatric Neurology Briefs, 1993
A four-year-old girl with Guillain-Barre syndrome that developed 10 days following H influenzae type b conjugate vaccine immunization is reported from Geneva, Switzerland.
J Gordon Millichap
doaj   +1 more source

New immunolatex spheres: visual markers of antigens on lymphocytes for scanning electron microscopy [PDF]

open access: yes, 1975
New immunochemical reagents consisting of antibodies bound to small latex spheres were used as visual markers for the detection and localization of cell surface antigens by scanning electron microscopy.
Dreyer, William J.   +3 more
core   +2 more sources

Does nocturnal light pollution impair immune function in a wild‐living amphibian?

open access: yesFunctional Ecology, EarlyView.
Read the free Plain Language Summary for this article on the Journal blog. Abstract Light pollution is among the most rapidly growing anthropogenic stressors on Earth. As it spreads far beyond its original source, it affects natural protected areas playing a key role in protecting biodiversity.
Louise Cheynel   +8 more
wiley   +1 more source

Роль протеиназ крови и их ингибиторов в механизмах противовирусной защиты [PDF]

open access: yes, 2011
Досліджено наявність трипсиноподібних протеїназ та їх інгібіторів у донорській крові людини, промислових відходах одержання гаммаглобуліну, комерційних вітчизняних препаратах (імуноглобулін, інтерферон, герпетична та туляремійна вакцини), у закордонних ...
Blaschke, A.P.   +5 more
core   +1 more source

Major Cat Allergen Fel d 4: Structure and Identification of a Cross‐Reactive IgE‐Epitope‐Containing Area

open access: yesAllergy, EarlyView.
This study reports the three‐dimensional structure of an important cat allergen, Fel d 4, that shares high homology with Equ c 1 (i.e., major horse allergen) and Can f 6 (i.e., dog allergen). The C‐terminal region of the Fel d 4 contains a major IgE‐reactive epitope.
Nikolina Todorović   +14 more
wiley   +1 more source

Subcutaneous IgG Replacement Therapy by Push in 32 Patients with Primary Immunodeficiency Diseases in Argentine [PDF]

open access: yes, 2014
Introduction: Regular replacement with immunoglobulin infusions is the mainstay of treatment in the majority of primary immunodeficiencies. Several studies showed that Subcutaneous Immunoglobulin (SCIG) has similar efficacy to Intravenous Immunoglobulin (
Bezrodnik, Liliana   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy